• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    5.67 Down 0.05(0.87%) 4:00PM EDT
    |After Hours : 5.67 0.00 (0.00%) 4:35PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.72
    Open:5.70
    Bid:5.56 x 300
    Ask:5.80 x 1000
    1y Target Est:7.00
    Beta:0.92
    Next Earnings Date: 5-Aug-15PDLI Earnings announcement
    Day's Range:5.62 - 5.78
    52wk Range:5.62 - 10.26
    Volume:2,076,814
    Avg Vol (3m):2,637,130
    Market Cap:930.40M
    P/E (ttm):2.96
    EPS (ttm):1.92
    Div & Yield:0.60 (10.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 0.87%930.40M
    AMGNDown 0.45%132.90B
    SGENUp 0.58%5.85B
    XOMAUp 0.84%91.91M

    Key Statistics

    Forward P/E (1 yr):9.30
    P/S (ttm):1.88
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.07
    Quarterly EPS Est (Jun-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback